awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28068643-2ECE6421-E759-4839-A661-EC86BCCBA227
Q28068643-2ECE6421-E759-4839-A661-EC86BCCBA227
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28068643-2ECE6421-E759-4839-A661-EC86BCCBA227
Focus on Alectinib and Competitor Compounds for Second-Line Therapy in ALK-Rearranged NSCLC
P2860
Q28068643-2ECE6421-E759-4839-A661-EC86BCCBA227
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28068643-2ECE6421-E759-4839-A661-EC86BCCBA227
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80b7c555db4cb0e6338c384874ee21f7d44653cd
P2860
Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK.